-1752956047131.webp&w=3840&q=75)
2025 NOSCM | Prostate Cancer: Early and Locally Advanced Disease
Overview
Dr. Ulka Vaishampayan discussed early and locally advanced prostate cancer, noting 192,000 new U.S. cases yearly. Key biomarkers include PSA, imaging, and genomics. High-risk cases may need surgery, radiation, or hormone therapy. Tools like Decipher and Artera AI aid decisions. Multidisciplinary care is key.
Target Audience
Physicians
Nurses
Pharmacists
Physician Associates
This material is non‑CME, no credits are available, and a certificate will not be provided upon completion.
Faculty
Ulka Vaishampayan, MD
Date of Release
July 20th, 2025